Pharmaceutical Technology Europe
New chemical entities with poor aqueous solubility require the use of technologies to enable sufficient oral bioavailability of these NCEs following administration.
William Porter III
Advertisement
William Porter III, is senior chemist, R&D, at Dow Pharma & Food Solutions.
Articles by William Porter III
Advertisement
Latest Updated Articles
Polymers for Solubility EnhancementAugust 1st 2014
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
FDA Duloxetine Recall Highlights Generic Manufacturing Quality Gaps
2
Germany Pharma Tariff Threat: What Manufacturers Need to Know
3
Why Pharma Dealmaking Slowed in Q1 2026 and What Is Coming Next
4
PharmTech Weekly Roundup—June 19, 2026
5